PIPERACILLIN AND TAZOBACTAM

Generic: PIPERACILLIN AND TAZOBACTAM

HospiraManufacturer
INTRAVENOUS, PARENTERALRoute
PIPERACILLIN SODIUMActive Substance
2010-10-21Original Approval

PIPERACILLIN AND TAZOBACTAM is FDA application ANDA065362, sponsored by SANDOZ. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
3,061 reports
2
OFF LABEL USE
2,648 reports
3
ACUTE KIDNEY INJURY
2,093 reports
4
PYREXIA
1,770 reports
5
CONDITION AGGRAVATED
1,146 reports
6
DIARRHOEA
1,110 reports
7
THROMBOCYTOPENIA
1,056 reports
8
PNEUMONIA
1,008 reports
9
NEUTROPENIA
974 reports
10
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
960 reports